Primer İmmün Yetmezliği Olan Hastalarda Tamamlayıcı ve Alternatif Tedavi Kullanımı

Öz

Amaç: Tamamlayıcı ve alternatif tedavi kullanımının çocuklarda giderek arttığı bildirilmektedir. Bu çalışmanın amacı, primer immün yetmezliği olan çocuklarda tamamlayıcı ve alternatif tedavi (TAM) kullanım sıklığını belirlemektir.Gereç ve Yöntemler: Primer immün yetmezlik tanısıyla takipli 2,5 ile 18 yaş arasında olan hastaların anne veya babalarına tamamlayıcı ve alternatif tedavi ile ilgili soruları içeren anket uygulandı.Bulgular: Hastaların 76’sı (%64.4) son 12 ayda tamamlayıcı ve alternatif tedavi kullanmıştı. Tamamlayıcı ve alternatif tedavi kullanımının yaş, cinsiyet, ortalama takip süresi ve primer immün yetmezlik türü ile herhangi bir ilişkisi yok iken, kontrollere düzenli gelen hastalarda ve intravenöz immünglobulin (İVİG), interferon-γ (IFN-γ) veya granülosit koloni sitimüle edici faktör (G-CSF) ile rutin tedavi yapılan hastalarda TAM kullanımı, anlamlı olarak daha düşük bulundu (P=0,019 ve P=0,033).Sonuç: Kontrollere düzenli gelmeyen ve rutin periyodik tıbbi tedavi almayan primer immün yetmezliği olan hastalarda TAM kullanımının yüksek olduğu görülmektedir.

Anahtar Kelimeler

• Alternatif tedavi, Bitkisel tedaviler, Diyet alışkanlıkları, İmmün yetmezlik

Complementary and Alternative Medicine in Patients with Primary Immunodeficiency

Öz

Objective: It has been reported that the use of complementary and alternative medicine is increasing in childhood. The aim of this study was to determine the frequency of CAM usage in children with primary immunodeficiency. Material and Methods: A survey was conducted to the parents of patients between the ages of 2.5 and 18 years diagnosed with primary immunodeficiency. results: Seventy-six (64.4%) of patients had used CAM in the last 12 months. We could not demonstrate any relationship between CAM usage and age, sex, duration of follow up and type of primary immunodeficiency. CAM usage was significantly low both in patients who came to the visits regularly and in patients who underwent a specific treatment with intravenous immune globulin (IVIG), interferon γ (IFn-γ) or granulocyte colony stimulating factor (G-CSF) (P=0.019 and P=0.033). conclusion: In the present study it was shown that use of CAM is high in patients with primary immunodeficiency who do not attend their regular control visits at the hospital and who are not under a specific medical treatment

Anahtar Kelimeler

• Alternative medicine, Herbal medicine, Diet habits, Immune deficiency

Kaynakça

1. Defining and describing complementary and alternative medicine. Panel on Definition and Description, CAM Research Methodology Conference, April 1995. Altern Ther Health Med 1997;3:49-57.
2. Kemper KJ, Vohra S, Walls R; American Academy of Pediatrics. The use of complementary and alternative medicine in pediatrics. Pediatrics 2008;122:1374-86.
3. Ernst E. Prevalence of complementary/alternative medicine for children: A systematic review. Eur J Pediatr 1999;158:7-11.
4. Featherstone C, Godden D, Selvaraj S, Emslie M, Took-zozaya M. Characteristics associated with reported CAM use in patients attending six GP practices in the Tayside and Grampian regions of Scotland: A survey. Complement Ther Med 2003;11:168-76.
5. Hameen-Anttila KP, niskala uR, Siponen SM, Ahonen RS. The use of complementary and alternative medicine products in preceding two days among Finnish parents - a population survey. BMC Complement Altern Med 2011;11:107.
6. Cohen MH, Kemper KJ. Complementary therapies in pediatrics: A legal perspective. Pediatrics 2005;115:774-80.
7. Hanssen B, Grimsgaard S, launso l, Fonnebo V, Falkenberg T, Rasmussen nK. use of complementary and alternative medicine in the Scandinavian countries. Scand J Prim Health Care 2005;23: 57-62.
8. Sinha D, Efron D. Complementary and alternative medicine use in children with attention deficit hyperactivity disorder. J Paediatr Child Health 2005;41:23-6.

9. levy SE, Hyman Sl. use of complementary and alternative treatments for children with autistic spectrum disorders is increasing. Pediatr Ann 2003;32:685-91.
10. lemay JF, Amin A, Pacaud D. Complementary and alternative medicine use in children and adolescents with type 1 diabetes. Paediatr Child Health 2011;16:468-72.
11. Karali Y, Saglam H, Karali z, Kilic SS. The use of complementary and alternative medicine in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 2011;21:480-3.
12. Orhan F, Sekerel BE, Kocabas Cn, Sackesen C, Adalioglu G, Tuncer A. Complementary and alternative medicine in children with asthma. Ann Allergy Asthma Immunol 2003;90:611-5.
13. Maclennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. lancet 1996;347:569-73.
14. Astin JA. Why patients use alternative medicine: Results of a national study. JAMA 1998;279:1548-53.
15. Eisenberg DM, Davis RB, Ettner Sl, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the united States, 1990-1997: Results of a follow-up national survey. JAMA 1998;280:1569-75.
16. Shen J, Oraka E. Complementary and alternative medicine (CAM) use among children with current asthma. Prev Med 2012;54: 27-31.
17. Shaw A, noble A, Salisbury C, Sharp D, Thompson E, Peters TJ. Predictors of complementary therapy use among asthma patients: Results of a primary care survey. Health Soc Care Community 2008;16:155-64.
18. Cassileth BR, Chapman CC. Alternative and complementary cancer therapies. Cancer 1996;77:1026-34.